Employees: 11 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2003-01-31 (23 years)Status: ActiveBusiness sector: Fabrication de matériel médico-chirurgical et dentaireLocation: MOUTIERS (54660), Meurthe-et-Moselle
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
LABORATOIRE RIEFOLO : revenue, balance sheet and financial ratios
LABORATOIRE RIEFOLO is a French company
founded 23 years ago,
specialized in the sector Fabrication de matériel médico-chirurgical et dentaire.
Based in MOUTIERS (54660),
this company of category PME
shows in 2022 a revenue of 1.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - LABORATOIRE RIEFOLO (SIREN 445172992)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
1 367 089 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
48 807 €
44 399 €
6 340 €
54 590 €
-21 038 €
32 580 €
108 291 €
70 937 €
17 329 €
EBITDA
N/C
N/C
25 077 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
0.5%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, LABORATOIRE RIEFOLO generates positive net income of 49 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 17 k€ -> 49 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
48 807 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 17%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 63%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
16.587%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
63.094%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
58.111
40.727
10.123
5.555
53.145
42.262
33.642
24.755
16.587
Financial autonomy
48.963
54.029
66.895
71.508
49.66
55.723
58.845
62.542
63.094
Repayment capacity
None
None
None
None
None
None
10.241
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
1.249%
None%
None%
Sector positioning
Debt ratio
16.592024
2022
2023
2024
Q1: 1.92
Med: 18.86
Q3: 55.42
Good-6 pts over 3 years
In 2024, the debt ratio of LABORATOIRE RIEFOLO (16.59) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
63.09%2024
2022
2023
2024
Q1: 24.8%
Med: 50.27%
Q3: 69.09%
Good
In 2024, the financial autonomy of LABORATOIRE RIEFOLO (63.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
10.24 years2022
2022
Q1: 0.0 years
Med: 0.51 years
Q3: 2.07 years
Watch
In 2022, the repayment capacity of LABORATOIRE RIEFOLO (10.24) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 154.86. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
101.602
96.862
109.997
131.036
189.849
254.715
222.748
203.77
154.863
Interest coverage
None
None
None
None
None
None
23.635
None
None
Sector positioning
Liquidity ratio
154.862024
2022
2023
2024
Q1: 159.64
Med: 253.69
Q3: 429.69
Watch-20 pts over 3 years
In 2024, the liquidity ratio of LABORATOIRE RIEFOLO (154.86) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
23.64x2022
2022
Q1: 0.0x
Med: 0.56x
Q3: 3.14x
Excellent
In 2022, the interest coverage of LABORATOIRE RIEFOLO (23.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution LABORATOIRE RIEFOLO
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
108 629 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
4
0
0
Customer payment term (days)
0
0
0
0
0
0
41
0
0
Supplier payment term (days)
0
0
0
0
0
0
47
0
0
Positioning of LABORATOIRE RIEFOLO in its sector
Comparison with sector Fabrication de matériel médico-chirurgical et dentaire
Valuation estimate
Based on 57 transactions of similar company sales
(all years),
the value of LABORATOIRE RIEFOLO is estimated at
148 650 €
(range 34 544€ - 293 132€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2024
57 tx
34k€148k€293k€
148 650 €Range: 34 544€ - 293 132€
NAF 5 all-time
Valuation method used
Net Income Multiple
48 807 €
×
3.0x
=148 651 €
Range: 34 544€ - 293 132€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Fabrication de matériel médico-chirurgical et dentaire)
Compare LABORATOIRE RIEFOLO with other companies in the same sector:
Frequently asked questions about LABORATOIRE RIEFOLO
What is the revenue of LABORATOIRE RIEFOLO ?
The revenue of LABORATOIRE RIEFOLO in 2022 is 1.4 M€.
Is LABORATOIRE RIEFOLO profitable?
Yes, LABORATOIRE RIEFOLO generated a net profit of 49 k€ in 2024.
Where is the headquarters of LABORATOIRE RIEFOLO ?
The headquarters of LABORATOIRE RIEFOLO is located in MOUTIERS (54660), in the department Meurthe-et-Moselle.
Where to find the tax return of LABORATOIRE RIEFOLO ?
The tax return of LABORATOIRE RIEFOLO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does LABORATOIRE RIEFOLO operate?
LABORATOIRE RIEFOLO operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart